跳至主要内容
临床试验/2024-515958-24-00
2024-515958-24-00招募中3 期

Preoperative Antibiotics for Mild or Moderate Acute Cholecystitis (POMMAC): A Non-inferiority, Open-label, Randomized Controlled Trial – Study Protocol

HUS-Yhtymae1 个研究点 分布在 1 个国家目标入组 456 人开始时间: 2025年4月7日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
456
试验地点
1
主要终点
The rate of postoperative infectious complications within 30 days from randomisation

研究概览

简要总结

To compare the effect of a single-dose of antibiotics versus continuous antibiotics preoperatively on the rate of postoperative infectious complications in patients undergoing cholecystectomy for acute cholecystitis.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Patients with diagnosed mild or moderate acute cholecystitis (according to Tokyo Guidelines)

排除标准

  • Age under 18 years
  • Class D drug-drug interactions
  • Tokyo Guidelines Grade III cholecystitis (see protocol)
  • subjects with reduced capacity for self-determination
  • Peritonitis
  • Suspicion of cholangitis (Charcot's triad or radiologic findings)
  • Bile duct stones
  • Allergy to all antibiotics in protocol
  • Antibiotics 24 hours prior to randomisation
  • Breastfeeding women

结局指标

主要结局

The rate of postoperative infectious complications within 30 days from randomisation

The rate of postoperative infectious complications within 30 days from randomisation

次要结局

  • The conversion rate from laparoscopic to open cholecystectomy during the primary operation
  • The Comprehensive Complication Index according to the Clavien-Dindo Classification within 30 days postoperatively
  • A composite outcome incorporating the rate of all antibiotic-related adverse outcomes (hypersensitivity reactions, clostridium difficile diarrhea, yeast infections) within 30 days postoperatively
  • The length of stay

研究者

发起方
HUS-Yhtymae
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Panu Mentula

Scientific

HUS-Yhtymae

研究点 (1)

Loading locations...

相似试验